Gene therapy for osteosarcoma: steps towards clinical studiesCrispin R. Dass; Peter F. M. Choong · 2008

Making gene therapy for osteosarcoma a realityBroadhead, Matthew L; Clark, Jonathan CM; Choong, Peter FM; Dass, Crispin R · Expert Review of Anticancer Therapy · 2010

Non-viral methods for gene transfer towards osteosarcoma therapyDass, Crispin R.; Choong, Peter F. M. · Journal of Drug Targeting · 2007

Evolving gene therapy approaches for osteosarcoma using viral vectors: ReviewM.A. Witlox; M.L. Lamfers; P.I.J.M. Wuisman; D.T. Curiel; G.P. Siegal · 2007

Limited specificity of promoter constructs for gene therapy in osteosarcoma.Pollmann, Annika; Kabisch, Hartmut; Block, Andreas; Müller, Jürgen; Hellwinkel, Olaf J C · International Journal of Molecular Medicine · 2004

Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcomaWang, Yu; Li, Lei; Shao, Naimin; Hu, Zhiqi; Chen, Hui; Xu, Leqin; Wang, Changping; Cheng, Yiyun; Xiao, Jianru · Acta Biomaterialia · 2015

Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin)Song, Sun U; Boyce, Frederick M · Experimental & Molecular Medicine · 2001

Computer model accurately predicts chemotherapy responseInpharma Weekly · 2006

AzodicarbonamideInpharma Weekly · 1999

Recommendations for treatment of severe aplastic anaemiaInpharma Weekly · 1994

Did you know about R&D costs?Inpharma Weekly · 1993

R&D investment in JapanInpharma Weekly · 1993

NICE creates new R&D committeeInpharma Weekly · 2003

Gallic acid has potential in lung cancerInpharma Weekly · 2002

New mesalazine formulation advantageous in IBDInpharma Weekly · 2001